Skip to content

Deborah B. Leiderman

2 papers in the library · 27 citations · publishing 2017-2018

Papers

Sort Most recent Most cited

Studies with psychedelic drugs in human volunteers.

Neuropharmacology November 2018 Edward M. Sellers, Myroslava K. Romach, Deborah B. Leiderman

Scientific curiosity and fascination have played a key role in human research with psychedelics along with the hope that perceptual alterations and heightened insight could benefit well-being and play a role in the treatment of various neuropsychiatric disorders. These motivations need to be tempered by a realistic assessment of the hurdles to be cleared for therapeutic use. Development of a...

Psychedelic Drugs as Therapeutics: No Illusions About the Challenges

Clinical Pharmacology & Therapeutics August 24, 2017 Edward M. Sellers, Deborah B. Leiderman 27 citations

Interest in the potential therapeutic benefits of psychedelic agents has recently increased. In addition to psilocybin, a wide variety of agents with psychedelic properties have been proposed and partially tested. However, the challenges of obtaining approval to market a restricted psychotomimetic agent are formidable.

DOI: 10.1002/cpt.776 (opens in new tab) Psilocybin Psychotomimetic Hallucinogen Illusion +3